Literature DB >> 12829436

Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells.

Hitoshi Ikeda1, Kayo Nagashima, Mikio Yanase, Tomoaki Tomiya, Masahiro Arai, Yukiko Inoue, Kazuaki Tejima, Takako Nishikawa, Masao Omata, Satoshi Kimura, Kenji Fujiwara.   

Abstract

Hepatic stellate cells (HSCs) play a central role in the development of hepatic fibrosis. Recent evidence has revealed that HSCs also play a role in its resolution, where HSC apoptosis was determined. Moreover, induction of HSC apoptosis caused a reduction of experimental hepatic fibrosis in rats. Thus knowing the mechanism of HSC apoptosis might be important to clarify the pathophysiology and establish the therapeutic strategy for hepatic fibrosis. In HSCs, Rho and Rho kinase are known to regulate contraction, migration, and proliferation with modulation of cell morphology. Controversy exists as to the participation of Rho and Rho kinase on cell survival, and little is known regarding this matter in HSCs. In this study, we directed our focus on the role of the Rho pathway in the regulation of HSC survival. C3, an inhibitor of Rho, increased histone-associated DNA fragmentation and caspase 3 activity with enhanced condensation of nuclear chromatin in rat cultured HSCs. Moreover, Y-27632, an inhibitor of Rho kinase, had the same effects, suggesting that inhibition of the Rho/Rho kinase pathway causes HSC apoptosis. On the other hand, lysophosphatidic acid, which stimulates the Rho/Rho kinase pathway, decreased histone-associated DNA fragmentation in HSCs. Inhibition of the Rho/Rho kinase pathway did not affect p53, Bcl-2, or Bax levels in HSCs. Thus we concluded that the Rho/Rho kinase pathway may play a role in the regulation of HSC survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829436     DOI: 10.1152/ajpgi.00039.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  18 in total

Review 1.  Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.

Authors:  Catharine A Street; Brad A Bryan
Journal:  Anticancer Res       Date:  2011-11       Impact factor: 2.480

2.  Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats.

Authors:  Xi-Xian Yao; Shu-Lin Jiang; You-Wei Tang; Dong-Mei Yao; Xin Yao
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

3.  Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells.

Authors:  Li Yao; Zhen-Min Yao; Heng Weng; Ge-Ping Zhao; Yue-Jun Zhou; Tao Yu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid.

Authors:  Frisca Frisca; Duncan E Crombie; Mirella Dottori; Yona Goldshmit; Alice Pébay
Journal:  J Lipid Res       Date:  2013-03-04       Impact factor: 5.922

5.  Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.

Authors:  M Hennenberg; J Trebicka; C Stark; A Z Kohistani; J Heller; T Sauerbruch
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

6.  Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.

Authors:  Jannette Rodriguez-Pallares; Ana I Rodriguez-Perez; Ana Muñoz; Juan A Parga; Juan J Toledo-Aral; Jose L Labandeira-Garcia
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

Review 7.  Rho kinase in the regulation of cell death and survival.

Authors:  Jianjian Shi; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-09       Impact factor: 4.291

8.  Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632.

Authors:  Marike Marjolijn van Beuge; Jai Prakash; Marie Lacombe; Eduard Post; Catharina Reker-Smit; Leonie Beljaars; Klaas Poelstra
Journal:  Pharm Res       Date:  2011-03-26       Impact factor: 4.200

9.  Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Authors:  Thomas Pleli; Daniel Martin; Bernd Kronenberger; Friederike Brunner; Verena Köberle; Georgios Grammatikos; Harald Farnik; Yolanda Martinez; Fabian Finkelmeier; Sandra Labocha; Nerea Ferreirós; Stefan Zeuzem; Albrecht Piiper; Oliver Waidmann
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

10.  Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study.

Authors:  Lai Wei; Juan Yang; Min Wang; Sheng-Nan Xu; Hua-Min Liang; Qi Zhou
Journal:  Int J Mol Med       Date:  2014-08-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.